Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4 Shares withheld for taxes Chief Financial Officer gave up 727 shares (to pay taxes)
  2. 4 Shares withheld for taxes CEO gave up 3,277 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Scientific Officer gave up 27,258 shares (to pay taxes)
  4. 4 Derivatives Options or other derivatives
  5. 4 Shares withheld for taxes INTERIM CEO gave up 3,559 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Scientific Officer gave up 11,317 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Financial Officer gave up 5,816 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Business Officer gave up 15,447 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Scientific Officer gave up 41,851 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Financial Officer gave up 38,221 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Business Officer gave up 40,664 shares (to pay taxes)
  12. 4 Shares withheld for taxes INTERIM CEO gave up 17,436 shares (to pay taxes)
  13. 4 Gift Chief Scientific Officer gave 15,000 shares (gift)
  14. 4 Shares withheld for taxes INTERIM CEO gave up 68,343 shares (to pay taxes)
  15. 4 Derivatives Options or other derivatives
  16. 4 Shares withheld for taxes INTERIM CEO gave up 2,721 shares (to pay taxes)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market buy Director bought 666,666 shares at $2.25 ($1,499,999)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,721 shares (to pay taxes)

Page 3 of 21 · 414 filings